|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
26
|
|
pubmed:dateCreated |
2006-9-11
|
|
pubmed:abstractText |
HER3 (erbB-3) is a member of the epidermal growth factor receptor (EGFR) family. After dimerization with other members of the EGFR family several signal transduction cascades can be activated, including phosphoinosite 3'-kinase (PI3-K)/Akt and extracellular signal-regulated kinase (ERK1/2). Here, we studied a possible association between HER3 expression and prognosis in patients with ovarian cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BauerAlexanderA,
pubmed-author:BezlerMartinM,
pubmed-author:BrulportMarcM,
pubmed-author:EdelmannJeanettJ,
pubmed-author:GebhardSusanneS,
pubmed-author:HasencleverDirkD,
pubmed-author:HengstlerJan GeorgJG,
pubmed-author:HermesMatthiasM,
pubmed-author:KrishnamurthiKK,
pubmed-author:LäuterJürgenJ,
pubmed-author:LessigRüdigerR,
pubmed-author:SchifferIlka BIB,
pubmed-author:SchmidtMarkusM,
pubmed-author:SchormannWiebkeW,
pubmed-author:SehouliJalidJ,
pubmed-author:SteinerEricE,
pubmed-author:SternKatjaK,
pubmed-author:TannerBernoB,
pubmed-author:UllrichAxelA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4317-23
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16896008-Carcinoma,
pubmed-meshheading:16896008-Female,
pubmed-meshheading:16896008-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16896008-Humans,
pubmed-meshheading:16896008-Immunohistochemistry,
pubmed-meshheading:16896008-Middle Aged,
pubmed-meshheading:16896008-Multivariate Analysis,
pubmed-meshheading:16896008-Neoplasm Staging,
pubmed-meshheading:16896008-Odds Ratio,
pubmed-meshheading:16896008-Ovarian Neoplasms,
pubmed-meshheading:16896008-Predictive Value of Tests,
pubmed-meshheading:16896008-Prognosis,
pubmed-meshheading:16896008-Proportional Hazards Models,
pubmed-meshheading:16896008-Receptor, erbB-2,
pubmed-meshheading:16896008-Receptor, erbB-3,
pubmed-meshheading:16896008-Survival Analysis,
pubmed-meshheading:16896008-Tumor Markers, Biological,
pubmed-meshheading:16896008-Up-Regulation
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
ErbB-3 predicts survival in ovarian cancer.
|
|
pubmed:affiliation |
Department of Gynecology and Obstetrics, University of Mainz, Mainz, Germany.
|
|
pubmed:publicationType |
Journal Article
|
